Evidence map›Paper›PMID 33623002›Full record

ArticleNature communications2021

The lytic polysaccharide monooxygenase CbpD promotes Pseudomonas aeruginosa virulence in systemic infection.

Fatemeh Askarian, Satoshi Uchiyama, Helen Masson, Henrik Vinther Sørensen, Ole Golten, Anne Cathrine Bunæs, Sophanit Mekasha, Åsmund Kjendseth Røhr, Eirik Kommedal, Judith Anita Ludviksen and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 97 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Redox robustness drives LPMO evolution.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Mimicking the Reactivity of LPMOs with a Mononuclear Cu Complex.European journal of inorganic chemistry · 2024
    Article
  18. Article
  19. Article
  20. Inhibition ofAntimicrobial agents and chemotherapy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 4 countries.

Fatemeh AskarianFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway. fatemeh.askarian@nmbu.no.ORCID 0000-0002-7438-4671
Satoshi Uchiyama *Division of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.
Helen Masson *Department of Pediatrics, University of California, San Diego, School of Medicine, La Jolla, CA, USA.
Henrik Vinther SørensenDepartment of Chemistry, University of Oslo, Oslo, Norway.ORCID 0000-0003-3057-5668
Ole GoltenFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway.
Anne Cathrine BunæsFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway.
Sophanit MekashaFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway.
Åsmund Kjendseth RøhrFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway.
Eirik KommedalFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway.ORCID 0000-0002-7502-4184
Judith Anita LudviksenResearch Laboratory, Nordland Hospital, Bodø, Norway.
Magnus Ø ArntzenFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway.ORCID 0000-0002-1803-727X
Benjamin SchmidtDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.
Raymond H ZurichDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.
Nina M van SorgeDepartment of Medical Microbiology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0002-2695-5863
Vincent G H EijsinkFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway.
Ute KrengelDepartment of Chemistry, University of Oslo, Oslo, Norway.ORCID 0000-0001-6688-8151
Tom Eirik MollnesResearch Laboratory, Nordland Hospital, Bodø, Norway.
Nathan E LewisDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA.ORCID 0000-0001-7700-3654
Victor NizetDivision of Host-Microbe Systems & Therapeutics, Department of Pediatrics, UC San Diego, La Jolla, CA, USA. vnizet@health.ucsd.edu.ORCID 0000-0003-3847-0422
Gustav Vaaje-KolstadFaculty of Chemistry, Biotechnology and Food Science, Norwegian University of Life Sciences (NMBU), Ås, Norway. gustav.vaaje-kolstad@nmbu.no.ORCID 0000-0002-3077-8003
Norwegian University of Life Sciences · NOUniversity of California San Diego · USUniversity of Oslo · NONordland Hospital · NONovo Nordisk Foundation · DKOslo University Hospital · NOUC San Diego Health System · USUtrecht University · NL

Funding

Overall Priority Score P41GM103694 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D · 2013 to 2018
$6.9M
Unraveling the mammalian secretory pathway through systems biology and algorithm developmentR35GM119850 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LEWIS, NATHAN ENOCH · 2016 to 2025
$4.3M
Protein-Glycan Interaction Resource of the CFGR24GM098791 · NIGMS · EMORY UNIVERSITY · PI CUMMINGS, RICHARD D, PAULSON, JAMES C · 2011 to 2013
$2.6M
Surprising Efficacy of Discounted Antibiotics vs. MDR Gram-Negative Pathogens Occurring Through Innate Immune SensitizationR01AI145310 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KUMARASWAMY, MONIKA, NIZET, VICTOR · 2020 to 2023
$1.9M
Safety and Dose Optimization of High-Dose Anakinra in Kawasaki DiseaseP50HD090259 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREMOULET, ADRIANA H · 2019 to 2020
$1.4M
NIAID NIH HHS R01 AI145310NICHD NIH HHS P50 HD090259NIGMS NIH HHS P41 GM103694NIGMS NIH HHS R24 GM098791NIGMS NIH HHS R35 GM119850
6 · The paper itself

Abstract

The recently discovered lytic polysaccharide monooxygenases (LPMOs), which cleave polysaccharides by oxidation, have been associated with bacterial virulence, but supporting functional data is scarce. Here we show that CbpD, the LPMO of Pseudomonas aeruginosa, is a chitin-oxidizing virulence factor that promotes survival of the bacterium in human blood. The catalytic activity of CbpD was promoted by azurin and pyocyanin, two redox-active virulence factors also secreted by P. aeruginosa. Homology modeling, molecular dynamics simulations, and small angle X-ray scattering indicated that CbpD is a monomeric tri-modular enzyme with flexible linkers. Deletion of cbpD rendered P. aeruginosa unable to establish a lethal systemic infection, associated with enhanced bacterial clearance in vivo. CbpD-dependent survival of the wild-type bacterium was not attributable to dampening of pro-inflammatory responses by CbpD ex vivo or in vivo. Rather, we found that CbpD attenuates the terminal complement cascade in human serum. Studies with an active site mutant of CbpD indicated that catalytic activity is crucial for virulence function. Finally, profiling of the bacterial and splenic proteomes showed that the lack of this single enzyme resulted in substantial re-organization of the bacterial and host proteomes. LPMOs similar to CbpD occur in other pathogens and may have similar immune evasive functions.

Indexed as

AnimalsBacterial ProteinsCarrier ProteinsCell DeathComplement System ProteinsHumansMiceMicrobial ViabilityMixed Function OxygenasesOxidation-ReductionPolysaccharidesProtein DomainsProteomeProteomicsPseudomonas aeruginosaPseudomonas InfectionsBacterial ProteinsCarrier Proteinschitin-binding protein D, Pseudomonas aeruginosaComplement System ProteinsMixed Function OxygenasesPolysaccharidesProteomeVirulence Factors

Identifiers

PMID33623002
PMCPMC7902821
OpenAlexW3131614063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.